Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era.
about
Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent eraImpact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents.Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.Controversies surrounding percutaneous coronary intervention in the diabetic patient.To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions.Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: A meta-analysis.Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization.
P2860
Q34528546-C4C8F2BC-810D-4BD8-A216-11D175D352B8Q36227047-B8ED13C9-55CF-41D7-9C21-42095DC5CE5EQ37138113-750180CA-5769-49D3-84D9-9E6CE91D6BE4Q38407905-2B3582E9-A822-483E-AE62-4DE3252649AFQ38720113-3A05EF75-21A5-4370-BD13-C2850A81CA70Q42344249-248B4F2B-AE53-4DE2-A116-7B6D73AD6B26Q43416261-C1594208-2C8F-4EAE-B2E9-D4BBFA90708FQ43831794-68C698A2-B081-424A-97E9-AFD1F1ADCF09Q44730084-09C7201F-A95D-4F0D-8066-CFBC303B1B0AQ48338450-92167C7A-E940-43BA-97BF-6A79BA8E202EQ49545899-7AFFA0B4-6411-48ED-AE7C-AC32364FA4A5
P2860
Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Complete versus incomplete rev ...... in the drug-eluting stent era.
@en
Complete versus incomplete rev ...... in the drug-eluting stent era.
@nl
type
label
Complete versus incomplete rev ...... in the drug-eluting stent era.
@en
Complete versus incomplete rev ...... in the drug-eluting stent era.
@nl
prefLabel
Complete versus incomplete rev ...... in the drug-eluting stent era.
@en
Complete versus incomplete rev ...... in the drug-eluting stent era.
@nl
P2093
P2860
P1433
P1476
Complete versus incomplete rev ...... in the drug-eluting stent era.
@en
P2093
Hyeon-Cheol Gwon
Jeong Euy Park
Jin-Ho Choi
Joo-Yong Hahn
Kyung Pyo Hong
Sang Hoon Lee
Sang-Yeub Lee
Young Bin Song
P2860
P2888
P304
P356
10.1007/S00380-011-0173-X
P577
2011-07-16T00:00:00Z